Annual ROE
-98.73%
-17.91%-22.16%
31 December 2023
Summary:
Cue Biopharma annual return on equity is currently -98.73%, with the most recent change of -17.91% (-22.16%) on 31 December 2023. During the last 3 years, it has fallen by -31.63% (-47.14%). CUE annual ROE is now -255.14% below its all-time high of -27.80%, reached on 31 December 2015.CUE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-142.28%
-9.94%-7.51%
30 September 2024
Summary:
Cue Biopharma quarterly return on equity is currently -142.28%, with the most recent change of -9.94% (-7.51%) on 30 September 2024. Over the past year, it has dropped by -42.54% (-42.65%). CUE quarterly ROE is now -343.65% below its all-time high of -32.07%, reached on 31 December 2016.CUE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CUE ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -22.2% | -42.6% |
3 y3 years | -47.1% | -126.1% |
5 y5 years | -21.0% | -5.0% |
CUE ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -61.4% | at low | -126.1% | at low |
5 y | 5 years | -61.4% | at low | -152.2% | at low |
alltime | all time | -255.1% | at low | -343.6% | +14.4% |
Cue Biopharma ROE History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -142.28%(+7.5%) |
June 2024 | - | -132.34%(+11.7%) |
Mar 2024 | - | -118.52%(+15.1%) |
Dec 2023 | -98.73%(+22.2%) | -102.93%(+3.2%) |
Sept 2023 | - | -99.74%(+6.7%) |
June 2023 | - | -93.50%(+6.7%) |
Mar 2023 | - | -87.64%(+1.3%) |
Dec 2022 | -80.82%(+32.1%) | -86.51%(+12.5%) |
Sept 2022 | - | -76.93%(+2.8%) |
June 2022 | - | -74.83%(+9.6%) |
Mar 2022 | - | -68.27%(+8.4%) |
Dec 2021 | -61.16%(-8.9%) | -63.00%(+0.1%) |
Sept 2021 | - | -62.92%(+11.5%) |
June 2021 | - | -56.42%(-8.3%) |
Mar 2021 | - | -61.51%(-4.8%) |
Dec 2020 | -67.10% | -64.64%(-10.6%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2020 | - | -72.31%(-16.9%) |
June 2020 | - | -87.03%(-21.8%) |
Mar 2020 | - | -111.27%(-2.6%) |
Dec 2019 | -82.88%(+1.6%) | -114.25%(-15.7%) |
Sept 2019 | - | -135.47%(+1.0%) |
June 2019 | - | -134.14%(+27.1%) |
Mar 2019 | - | -105.50%(+20.3%) |
Dec 2018 | -81.57%(+116.3%) | -87.72%(+19.2%) |
Sept 2018 | - | -73.62%(+3.6%) |
June 2018 | - | -71.09%(-15.8%) |
Mar 2018 | - | -84.40%(-9.6%) |
Dec 2017 | -37.71%(-25.3%) | -93.37%(-43.8%) |
Sept 2017 | - | -166.26%(+56.9%) |
June 2017 | - | -105.97%(+95.7%) |
Mar 2017 | - | -54.15%(+68.8%) |
Dec 2016 | -50.47%(+81.5%) | -32.07% |
Dec 2015 | -27.80% | - |
FAQ
- What is Cue Biopharma annual return on equity?
- What is the all time high annual ROE for Cue Biopharma?
- What is Cue Biopharma annual ROE year-on-year change?
- What is Cue Biopharma quarterly return on equity?
- What is the all time high quarterly ROE for Cue Biopharma?
- What is Cue Biopharma quarterly ROE year-on-year change?
What is Cue Biopharma annual return on equity?
The current annual ROE of CUE is -98.73%
What is the all time high annual ROE for Cue Biopharma?
Cue Biopharma all-time high annual return on equity is -27.80%
What is Cue Biopharma annual ROE year-on-year change?
Over the past year, CUE annual return on equity has changed by -17.91% (-22.16%)
What is Cue Biopharma quarterly return on equity?
The current quarterly ROE of CUE is -142.28%
What is the all time high quarterly ROE for Cue Biopharma?
Cue Biopharma all-time high quarterly return on equity is -32.07%
What is Cue Biopharma quarterly ROE year-on-year change?
Over the past year, CUE quarterly return on equity has changed by -42.54% (-42.65%)